Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amicus Therapeutics Inc (NASDAQ:FOLD)

During the Trading Day
11.53 +0.20 / +1.77%
As of 12:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
11.53 0.00 / 0.00%
Volume: 8.8K
Health Technology

Company Description

Amicus Therapeutics, Inc. is a biopharmaceutical company focuses on the discovery, development and commercialization of orally administered, small molecule drugs known as pharmacological chaperones for the treatment of rare diseases, pharmacological chaperones are a novel, first-in-class approach to treating a broad range of diseases, including lysosomal storage disorders and diseases of neurodegeneration. Amicus develops pharmacological chaperones oral therapies that bind to and stabilize the affected proteins, restoring their shape, proper trafficking, and biological activity. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ.

Contact Information

Amicus Therapeutics, Inc.
1 Cedar Brook Drive
Cranbury New Jersey 08512
P:(609) 662-2000
Investor Relations:
(609) 662-5044



Other institutional61.32%
Mutual fund holders48.33%
Individual stakeholders38.45%

Top Executives

John Francis CrowleyChairman & Chief Executive Officer
Bradley L. CampbellPresident & Chief Operating Officer
William D. BairdChief Financial Officer
Ken ValenzanoSenior Vice President-Preclinical Research
Enrique DiloneSenior Vice President-Technical Operations